Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Tenax Therapeutics, Inc. (TENX) had Operating Cash Flow per Share of $-0.97 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-17.60M |
|
-- |
|
-- |
|
$19.49M |
|
$-19.49M |
|
$1.89M |
|
$-17.60M |
|
$-17.60M |
|
$-17.60M |
|
$-17.60M |
|
$-17.60M |
|
$-17.60M |
|
$-19.49M |
|
$-19.49M |
|
15.27M |
|
15.27M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$96.69M |
|
-- |
|
-- |
|
$96.69M |
|
$4.69M |
|
-- |
|
-- |
|
$4.69M |
|
$91.99M |
|
$91.99M |
|
$91.99M |
|
3.42M |
|
| Cash Flow Statement Financials | |
$-14.81M |
|
-- |
|
$99.87M |
|
$9.79M |
|
$94.85M |
|
$85.06M |
|
$1.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.13% |
|
-19.13% |
|
-18.21% |
|
-19.13% |
|
$26.89 |
|
$-0.97 |
|
|
Operating Cash Flow per Share |
$-0.97 |